Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Vote in favor of your Favored Travel Movement - 2The Most recent Microsoft Surface Genius PC: Ideal for Very good quality Planning and Gaming Needs
- 3Pick Your Favored kind of books
- 4Best Amusement Park in Asia: Which One Is a Must-Visit
- 5Merck sees over $5 billion opportunity in Cidara's experimental flu drug
- WHO suspends medical evacuations from Gaza following death of contractor in 'security incident'
- French rapper Gims placed under investigation for 'aggravated money laundering'
- Wizz CEO: We’re going to invest $1 b. in Israeli market
- Factbox-China's crewed lunar programme eyes astronaut landing by 2030
- Examination In progress into Abuse of Japanese Government-Supported Advance
- High Court freezes government move to shutter Army Radio pending ruling
- The most effective method to Pick the Right Material Organization: Your Definitive Aide
- Central African Republic's president sworn in for a third term after disputed election
- Under pressure at home, Belgium's leader treads a tight rope with EU partners over funds for Ukraine
